Opioid salts and formulations exhibiting anti-abuse and anti-dumping properties

A drug substance with a pharmaceutically acceptable organic acid addition salt of an opioid wherein said organic acid is selected from Structure A: wherein R1-R4 are independently selected from H, alkyl or substituted alkyl of 1-6 carbons, adjacent groups may be taken together to form a cyclic alkyl...

Full description

Saved in:
Bibliographic Details
Main Authors D'AMBROSIO STEPHEN G, KING CLIFFORD RILEY, BRISTOL DAVID W, ENGLISH MICHAEL L
Format Patent
LanguageEnglish
Published 10.06.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A drug substance with a pharmaceutically acceptable organic acid addition salt of an opioid wherein said organic acid is selected from Structure A: wherein R1-R4 are independently selected from H, alkyl or substituted alkyl of 1-6 carbons, adjacent groups may be taken together to form a cyclic alkyl, cyclic alkyl-aryl, or cyclic aryl moiety; R5 is selected from H, or an alkali earth cation; R6 and R7 are independently selected from H, alkyl of 1-6 carbons, an alkali earth cation, and aryl of 6 to 12 carbons, in a number sufficient to complete the valence bonding of X, and wherein X is selected from nitrogen, oxygen or sulfur; and wherein the drug substance has a morphology selected from amorphous and crystalline.
Bibliography:Application Number: US201113331298